Green synthesis of selenium based N-heterocyclic carbene compounds; structural, in-vitro anticancer and molecular docking studies. 2021

Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
Department of Chemistry, Quaid-I-Azam University, Islamabad 45320, Pakistan; Department of Chemistry, Government P/G College of Science, Faisalabad 38000, Pakistan.

Benzimidazolium salts (3-6) were synthesized as stable N-Heterocyclic Carbene (NHC) precursors and their selenium-NHC compounds/Selenones (7-10) were prepared using water as a solvent. Characterization of each of the synthesized compounds was carried out by various analytical and spectroscopic (FT-IR, 1H-, 13C NMR) methods. X-ray crystallographic analyses of single crystals obtained for salts 3 and 5 were carried out. Synthesized salts and their Se-NHCs were tested in-vitro for their anticancer potential against Cervical Cancer Cell line from Henrietta Lacks (HeLa), Breast cancer cell line (MDA-MB-231), Adenocarcinoma cell line (A549) and human normal endothelial cell line (EA.hy926). MTT assay was used for analysis and compared with standard drug 5-flourouracil. Benzimidazolium salts (3-6) and their selenium counter parts (7-10) were found potent anticancer agents. Salt 3-5 were found to be potent anticancer against HeLa with IC50 values 0.072, 0.017 and 0.241 μM, respectively, which are less than standard drug (4.9 μM). The Se-NHCs (7-10) had also shown significant anticancer potential against HeLa with IC50 values less than standard drug. Salts 3, 4 against EA.hy926, compounds 3,5,6, and 10 against MDA-MB-321, and compounds 4, 10 against A-549 cell line were found more potent anticancer agents with IC50 values less than standard drug. Molecular docking for (7-10) showed their good anti-angiogenic potential having low binding energy and significant inhibition constant values with VEGFA (vascular endothelial growth factor), EGF (human epidermal growth factor), COX1 (cyclooxygenase-1) and HIF (hypoxia inducible factor).

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008697 Methane The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012643 Selenium An element with the atomic symbol Se, atomic number 34, and atomic weight 78.97. It is an essential micronutrient for mammals and other animals but is toxic in large amounts. Selenium protects intracellular structures against oxidative damage. It is an essential component of GLUTATHIONE PEROXIDASE. Selenium-80,Selenium 80
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D060326 Chemistry Techniques, Synthetic Methods used for the chemical synthesis of compounds. Included under this heading are laboratory methods used to synthesize a variety of chemicals and drugs. Inorganic Synthesis,Inorganic Synthesis Methods,Inorganic Synthesis Techniques,Methods of Inorganic Synthesis,Methods of Organic Synthesis,Methods of Peptide Synthesis,Organic Synthesis,Organic Synthesis Methods,Organic Synthesis Techniques,Peptide Synthesis Methods,Peptide Synthesis Techniques,Peptide Synthesis, Synthetic,Synthetic Chemistry Techniques,Synthetic Peptide Synthesis,Chemistry Technique, Synthetic,Inorganic Syntheses,Inorganic Synthesis Method,Inorganic Synthesis Technique,Method, Inorganic Synthesis,Method, Organic Synthesis,Method, Peptide Synthesis,Methods, Inorganic Synthesis,Methods, Organic Synthesis,Methods, Peptide Synthesis,Organic Syntheses,Organic Synthesis Technique,Peptide Syntheses, Synthetic,Peptide Synthesis Method,Peptide Synthesis Technique,Syntheses, Inorganic,Syntheses, Organic,Syntheses, Synthetic Peptide,Synthesis Method, Inorganic,Synthesis Method, Peptide,Synthesis Methods, Inorganic,Synthesis Methods, Peptide,Synthesis Technique, Inorganic,Synthesis Technique, Organic,Synthesis Technique, Peptide,Synthesis Techniques, Inorganic,Synthesis Techniques, Organic,Synthesis Techniques, Peptide,Synthesis, Inorganic,Synthesis, Organic,Synthesis, Synthetic Peptide,Synthetic Chemistry Technique,Synthetic Peptide Syntheses,Technique, Inorganic Synthesis,Technique, Organic Synthesis,Technique, Peptide Synthesis,Technique, Synthetic Chemistry,Techniques, Inorganic Synthesis,Techniques, Organic Synthesis,Techniques, Peptide Synthesis,Techniques, Synthetic Chemistry

Related Publications

Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
September 2021, Chemical biology & drug design,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
September 2019, Bioorganic chemistry,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
August 2022, Heliyon,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
April 2022, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
August 2022, Molecules (Basel, Switzerland),
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
June 2023, ACS omega,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
September 2006, Dalton transactions (Cambridge, England : 2003),
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
March 2014, European journal of medicinal chemistry,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
October 2021, ChemMedChem,
Khizar Hayat, and Umaira Tariq, and Qin Ai Wong, and Ching Kheng Quah, and Aman Shah Abdul Majid, and Mansoureh Nazari V, and Mohamed B Khadeer Ahamed, and Muhammad Adnan Iqbal, and Syed Ahmed Tirmizi
September 2021, Molecules (Basel, Switzerland),
Copied contents to your clipboard!